Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Does BCBS Cover Wegovy
2.2.6 MORF-057 MORF-057 is an oral small-molecule inhibitor of 47 integrin that blocks lymphocyte recruitment to the gut and was evaluated in the EMERALD-1 study (NCT05291689), an open-label Phase 2a single-arm multicenter trial where 35 participants with moderately to severely active UC received 100 mg twice daily for 52 weeks following a 6-week screening period
(1996) 51A:B919
Investigation of phytochemicals and anti-convulsant activity of the plant Coleus amboinicus (lour.)
This no-reflow is associated with reduced left ventricular ejection fraction, increased infarct size and death
US$ 29.13
US$ 23.67
US$ 23.75
